Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
srx-246 (1 trial)
topiramate (topamax) (1 trial)
Huntington Disease (Phase 2)
Metabolic Syndrome (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Syndrome (Phase 2)
Trials (2 total)
Trial APIs (2 total)